BioCirc Vinkel Biogas ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 1.0% 1.4% 0.4% 0.4%  
Credit score (0-100)  70 87 77 100 100  
Credit rating  A A A AAA AAA  
Credit limit (mDKK)  0.0 1.5 0.5 34.5 37.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12

Net sales  0 0 0 566 427  
Gross profit  -0.1 20.0 71.8 112 77.9  
EBITDA  -0.1 16.9 63.5 96.1 63.1  
EBIT  -0.1 11.1 40.8 44.7 32.9  
Pre-tax profit (PTP)  -0.1 7.5 30.2 33.1 18.2  
Net earnings  -0.1 5.8 23.5 25.7 14.2  
Pre-tax profit without non-rec. items  -0.1 7.5 30.2 33.1 18.2  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12

Tangible assets total  213 321 324 684 687  
Shareholders equity total  9.9 15.7 39.3 300 315  
Interest-bearing liabilities  90.0 150 167 274 301  
Balance sheet total (assets)  222 383 408 807 840  

Net Debt  87.3 150 167 270 252  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12

Net sales  0 0 0 566 427  
Net sales growth  0.0% 0.0% 0.0% 0.0% -24.6%  
Gross profit  -0.1 20.0 71.8 112 77.9  
Gross profit growth  -429.9% 0.0% 259.8% 55.9% -30.5%  
Employees  1 9 14 18 22  
Employee growth %  0.0% 800.0% 55.6% 28.6% 22.2%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  222 383 408 807 840  
Balance sheet change%  341,549.1% 73.0% 6.4% 97.8% 4.2%  
Added value  -0.1 16.9 63.5 67.3 63.1  
Added value %  0.0% 0.0% 0.0% 11.9% 14.8%  
Investments  213 101 -19 13 279  

Net sales trend  0.0 0.0 0.0 0.0 -1.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 17.0% 14.8%  
EBIT %  0.0% 0.0% 0.0% 7.9% 7.7%  
EBIT to gross profit (%)  92.3% 55.8% 56.9% 39.9% 42.3%  
Net Earnings %  0.0% 0.0% 0.0% 4.5% 3.3%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 13.6% 10.4%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 5.8% 4.3%  
ROA %  -0.0% 3.7% 10.3% 7.4% 4.1%  
ROI %  -0.1% 5.7% 17.6% 10.0% 4.7%  
ROE %  -1.4% 45.4% 85.5% 15.1% 4.6%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
Equity ratio %  4.5% 4.1% 9.6% 37.2% 37.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 71.8% 99.9%  
Relative net indebtedness %  0.0% 0.0% 0.0% 71.0% 88.3%  
Net int. bear. debt to EBITDA, %  -173,729.6% 887.4% 263.5% 280.8% 399.5%  
Gearing %  907.2% 953.3% 425.9% 91.3% 95.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.1% 3.0% 6.7% 5.3% 5.3%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.4 0.6 1.3 1.2  
Current Ratio  0.3 0.7 0.8 1.7 1.5  
Cash and cash equivalent  2.7 0.5 0.0 4.5 49.2  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 45.4 48.4  
Trade creditors turnover (days)  0.0 0.0 0.0 29.0 23.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 21.8% 35.9%  
Net working capital  -21.9 -22.8 -27.7 50.9 51.4  
Net working capital %  0.0% 0.0% 0.0% 9.0% 12.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 31 19  
Added value / employee  -0 2 5 4 3  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -0 2 5 5 3  
EBIT / employee  -0 1 3 2 1  
Net earnings / employee  -0 1 2 1 1